How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
ConclusionsThe effects of CRT for recurrent cancers are not influenced by neoadjuvant chemotherapy, even when using the same anticancer agent. Chemotherapy is an acceptable treatment for patients who do not receive presurgical treatment.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Yusuke Taniyama,
Tadashi Sakurai,
Makoto Hikage,
Hiroshi Okamoto,
Chiaki Sato,
Kai Takaya,
Michiaki Unno,
Takashi Kamei Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagectomy | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma | Study